{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T12:32:47Z","timestamp":1788957167777,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes","doi-asserted-by":"publisher","award":["NHRI 13A1-CGGP14-051"],"award-info":[{"award-number":["NHRI 13A1-CGGP14-051"]}],"id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Epidemiol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s10654-024-01181-x","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T05:28:03Z","timestamp":1733203683000},"page":"1341-1351","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Hormone therapy and venous thromboembolism risk in women of menopausal age: a target trial emulation"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-4307-4218","authenticated-orcid":false,"given":"Yi-Chun","family":"Yeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Cherry Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2529-8125","authenticated-orcid":false,"family":"Yi Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8713-8816","authenticated-orcid":false,"given":"Pei-Chun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,3]]},"reference":[{"issue":"4","key":"1181_CR1","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1001\/jamainternmed.2014.8063","volume":"175","author":"NE Avis","year":"2015","unstructured":"Avis NE, Crawford SL, Greendale G, et al. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med. 2015;175(4):531\u20139. https:\/\/doi.org\/10.1001\/jamainternmed.2014.8063.","journal-title":"JAMA Intern Med"},{"issue":"4","key":"1181_CR2","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1080\/13697137.2016.1196047","volume":"19","author":"TJ de Villiers","year":"2016","unstructured":"de Villiers TJ, Hall JE, Pinkerton JV, et al. Revised global Consensus Statement on menopausal hormone therapy. Climacteric. 2016;19(4):313\u20135. https:\/\/doi.org\/10.1080\/13697137.2016.1196047.","journal-title":"Climacteric"},{"issue":"10","key":"1181_CR3","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1093\/eurheartj\/ehaa1044","volume":"42","author":"A Maas","year":"2021","unstructured":"Maas A, Rosano G, Cifkova R, et al. Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists. Eur Heart J. 2021;42(10):967\u201384. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa1044.","journal-title":"Eur Heart J"},{"issue":"7","key":"1181_CR4","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1097\/gme.0000000000002028","volume":"29","author":"North American Menopause Society","year":"2022","unstructured":"North American Menopause Society. The 2022 hormone therapy position statement of the North American Menopause Society. Menopause. 2022;29(7):767\u201394. https:\/\/doi.org\/10.1097\/gme.0000000000002028.","journal-title":"Menopause"},{"issue":"7","key":"1181_CR5","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1097\/gme.0000000000000921","volume":"24","author":"North American Menopause Society","year":"2017","unstructured":"North American Menopause Society. The 2017 hormone therapy position statement of the North American Menopause Society. Menopause. 2017;24(7):728\u201353. https:\/\/doi.org\/10.1097\/gme.0000000000000921.","journal-title":"Menopause"},{"issue":"5","key":"1181_CR6","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1001\/jama.2022.24140","volume":"329","author":"CJ Crandall","year":"2023","unstructured":"Crandall CJ, Mehta JM, Manson JE. Management of menopausal symptoms: a review. JAMA. 2023;329(5):405\u201320. https:\/\/doi.org\/10.1001\/jama.2022.24140.","journal-title":"JAMA"},{"issue":"3","key":"1181_CR7","doi-asserted-by":"publisher","first-page":"Cd002229","DOI":"10.1002\/14651858.CD002229.pub4","volume":"2015","author":"HM Boardman","year":"2015","unstructured":"Boardman HM, Hartley L, Eisinga A, et al. Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev. 2015;2015(3):Cd002229. https:\/\/doi.org\/10.1002\/14651858.CD002229.pub4.","journal-title":"Cochrane Database Syst Rev"},{"key":"1181_CR8","doi-asserted-by":"publisher","first-page":"k4810","DOI":"10.1136\/bmj.k4810","volume":"364","author":"Y Vinogradova","year":"2019","unstructured":"Vinogradova Y, Coupland C, Hippisley-Cox J. Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ. 2019;364:k4810. https:\/\/doi.org\/10.1136\/bmj.k4810.","journal-title":"BMJ"},{"issue":"13","key":"1181_CR9","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1001\/jama.292.13.1573","volume":"292","author":"M Cushman","year":"2004","unstructured":"Cushman M, Kuller LH, Prentice R, et al. Estrogen plus progestin and risk of venous thrombosis. JAMA. 2004;292(13):1573\u201380. https:\/\/doi.org\/10.1001\/jama.292.13.1573.","journal-title":"JAMA"},{"issue":"14","key":"1181_CR10","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","volume":"291","author":"GL Anderson","year":"2004","unstructured":"Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the women\u2019s Health Initiative randomized controlled trial. JAMA. 2004;291(14):1701\u201312. https:\/\/doi.org\/10.1001\/jama.291.14.1701.","journal-title":"JAMA"},{"key":"1181_CR11","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jclinepi.2016.04.014","volume":"79","author":"MA Hern\u00e1n","year":"2016","unstructured":"Hern\u00e1n MA, Sauer BC, Hern\u00e1ndez-D\u00edaz S, Platt R, Shrier I. Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses. J Clin Epidemiol. 2016;79:70\u20135. https:\/\/doi.org\/10.1016\/j.jclinepi.2016.04.014.","journal-title":"J Clin Epidemiol"},{"issue":"8","key":"1181_CR12","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1093\/aje\/kwv254","volume":"183","author":"MA Hern\u00e1n","year":"2016","unstructured":"Hern\u00e1n MA, Robins JM. Using Big Data to emulate a target Trial when a Randomized Trial is not available. Am J Epidemiol. 2016;183(8):758\u201364. https:\/\/doi.org\/10.1093\/aje\/kwv254.","journal-title":"Am J Epidemiol"},{"issue":"10","key":"1181_CR13","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1038\/s41591-019-0597-x","volume":"25","author":"BA Dickerman","year":"2019","unstructured":"Dickerman BA, Garc\u00eda-Alb\u00e9niz X, Logan RW, Denaxas S, Hern\u00e1n MA. Avoidable flaws in observational analyses: an application to statins and cancer. Nat Med. 2019;25(10):1601\u20136. https:\/\/doi.org\/10.1038\/s41591-019-0597-x.","journal-title":"Nat Med"},{"issue":"3","key":"1181_CR14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"JE Rossouw","year":"2002","unstructured":"Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women\u2019s Health Initiative randomized controlled trial. JAMA. 2002;288(3):321\u201333. https:\/\/doi.org\/10.1001\/jama.288.3.321.","journal-title":"JAMA"},{"issue":"9","key":"1181_CR15","doi-asserted-by":"publisher","first-page":"680","DOI":"10.7326\/0003-4819-136-9-200205070-00011","volume":"136","author":"J Miller","year":"2002","unstructured":"Miller J, Chan BK, Nelson HD. Postmenopausal estrogen replacement and risk for venous thromboembolism: a systematic review and meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;136(9):680\u201390. https:\/\/doi.org\/10.7326\/0003-4819-136-9-200205070-00011.","journal-title":"Ann Intern Med"},{"issue":"7","key":"1181_CR16","doi-asserted-by":"publisher","first-page":"869","DOI":"10.4158\/ep171828.Ps","volume":"23","author":"RH Cobin","year":"2017","unstructured":"Cobin RH, Goodman NF. American Association of Clinical Endocrinologists and American College of Endocrinology Position statement on menopause-2017 update. Endocr Pract. 2017;23(7):869\u201380. https:\/\/doi.org\/10.4158\/ep171828.Ps.","journal-title":"Endocr Pract"},{"issue":"3","key":"1181_CR17","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1742-7843.2006.pto_329.x","volume":"98","author":"MA Hern\u00e1n","year":"2006","unstructured":"Hern\u00e1n MA, Lanoy E, Costagliola D, Robins JM. Comparison of dynamic treatment regimes via inverse probability weighting. Basic Clin Pharmacol Toxicol. 2006;98(3):237\u201342. https:\/\/doi.org\/10.1111\/j.1742-7843.2006.pto_329.x.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"1181_CR18","unstructured":"Ministry of Health and Welfare. Table 8 Social Insurance. Ministry of Health and Welfare, Taipei, Taiwan. 2022. https:\/\/www.mohw.gov.tw\/dl-63152-60fccf9b-ef10-4856-97c0-dfeda0cdd6a7.html. Accessed 23 July 2024."},{"issue":"6","key":"1181_CR19","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1097\/EDE.0b013e31823029dd","volume":"22","author":"CJ Howe","year":"2011","unstructured":"Howe CJ, Cole SR, Westreich DJ, Greenland S, Napravnik S, Eron JJ. Jr. Splines for trend analysis and continuous confounder control. Epidemiology. 2011;22(6):874\u20135. https:\/\/doi.org\/10.1097\/EDE.0b013e31823029dd.","journal-title":"Epidemiology"},{"issue":"3","key":"1181_CR20","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/EDE.0b013e3181d61eeb","volume":"21","author":"M Lipsitch","year":"2010","unstructured":"Lipsitch M, Tchetgen Tchetgen E, Cohen T. Negative controls: a tool for detecting confounding and bias in observational studies. Epidemiology. 2010;21(3):383\u20138. https:\/\/doi.org\/10.1097\/EDE.0b013e3181d61eeb.","journal-title":"Epidemiology"},{"issue":"8","key":"1181_CR21","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1002\/sim.8471","volume":"39","author":"JG Young","year":"2020","unstructured":"Young JG, Stensrud MJ, Tchetgen Tchetgen EJ, Hern\u00e1n MA. A causal framework for classical statistical estimands in failure-time settings with competing events. Stat Med. 2020;39(8):1199\u2013236. https:\/\/doi.org\/10.1002\/sim.8471.","journal-title":"Stat Med"},{"key":"1181_CR22","unstructured":"The American Cancer Society medical and editorial content team. How smoking tobacco affects your cancer risk. American Cancer Society. 2020. https:\/\/www.cancer.org\/cancer\/risk-prevention\/tobacco\/health-risks-of-tobacco\/health-risks-of-smoking-tobacco.html. Accessed June 17, 2024."},{"key":"1181_CR23","unstructured":"Underferth D. How does obesity cause cancer? MD Anderson Center. https:\/\/www.mdanderson.org\/publications\/focused-on-health\/how-does-obesity-cause-cancer.h27Z1591413.html"},{"issue":"1","key":"1181_CR24","doi-asserted-by":"publisher","first-page":"20631","DOI":"10.1038\/s41598-020-77534-9","volume":"10","author":"JE Kim","year":"2020","unstructured":"Kim JE, Chang JH, Jeong MJ, et al. A systematic review and meta-analysis of effects of menopausal hormone therapy on cardiovascular diseases. Sci Rep. 2020;10(1):20631. https:\/\/doi.org\/10.1038\/s41598-020-77534-9.","journal-title":"Sci Rep"},{"key":"1181_CR25","doi-asserted-by":"publisher","first-page":"e6409","DOI":"10.1136\/bmj.e6409","volume":"345","author":"LL Schierbeck","year":"2012","unstructured":"Schierbeck LL, Rejnmark L, Tofteng CL, et al. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ. 2012;345:e6409. https:\/\/doi.org\/10.1136\/bmj.e6409.","journal-title":"BMJ"},{"issue":"13","key":"1181_CR26","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1056\/NEJMoa1505241","volume":"374","author":"HN Hodis","year":"2016","unstructured":"Hodis HN, Mack WJ, Henderson VW, et al. Vascular effects of early versus late postmenopausal treatment with Estradiol. N Engl J Med. 2016;374(13):1221\u201331. https:\/\/doi.org\/10.1056\/NEJMoa1505241.","journal-title":"N Engl J Med"},{"key":"1181_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-1586-3","volume-title":"Fundamentals of clinical trials","author":"LM Friedman","year":"2010","unstructured":"Friedman LM, Furberg CD, DeMets DL. Fundamentals of clinical trials. Fourth ed: Springer; 2010."},{"issue":"1","key":"1181_CR28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1177\/1740774511420743","volume":"9","author":"MA Hern\u00e1n","year":"2012","unstructured":"Hern\u00e1n MA, Hern\u00e1ndez-D\u00edaz S. Beyond the intention-to-treat in comparative effectiveness research. Clin Trials. 2012;9(1):48\u201355. https:\/\/doi.org\/10.1177\/1740774511420743.","journal-title":"Clin Trials"},{"issue":"2","key":"1181_CR29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.6118\/jmm.20000","volume":"26","author":"SR Lee","year":"2020","unstructured":"Lee SR, Cho MK, Cho YJ, et al. The 2020 menopausal hormone therapy guidelines. J Menopausal Med. 2020;26(2):69\u201398. https:\/\/doi.org\/10.6118\/jmm.20000.","journal-title":"J Menopausal Med"},{"key":"1181_CR30","unstructured":"NHS. When to take hormone replacement therapy (HRT). 2023. https:\/\/www.nhs.uk\/medicines\/hormone-replacement-therapy-hrt\/when-to-take-hormone-replacement-therapy-hrt\/"}],"container-title":["European Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-024-01181-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10654-024-01181-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-024-01181-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T06:08:33Z","timestamp":1735279713000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10654-024-01181-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1181"],"URL":"https:\/\/doi.org\/10.1007\/s10654-024-01181-x","relation":{},"ISSN":["0393-2990","1573-7284"],"issn-type":[{"value":"0393-2990","type":"print"},{"value":"1573-7284","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"19 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective cohort study was approved by the Institutional Review Board of the China Medical University Hospital (IRB: CMUH110-REC1-234). The requirement for informed consent was waived because this was a secondary analysis of deidentified data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}